Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 December 2007, Vol. 110, No. 12, pp. 3968-3977.
Prepublished online as a Blood First Edition Paper on August 21, 2007; DOI 10.1182/blood-2007-01-071167.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
blood-2007-01-071167v1
110/12/3968    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brenner, D.
Right arrow Articles by Arnold, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brenner, D.
Right arrow Articles by Arnold, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted January 31, 2007
Accepted August 13, 2007

Caspase cleaved HPK1 induces CD95L-independent activation-induced cell death in T and B lymphocytes

Dirk Brenner, Alexander Golks, Mareike Becker, Wolfgang Muller, Christian R Frey, Rostislav Novak, Doron Melamed, Friedemann Kiefer, Peter H Krammer, and Rudiger Arnold*

Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany
Department of Immunology, Faculty of Medicine, Technion, Haifa, Israel
Vascular Cell Biology, Max-Planck-Institute for Molecular Biomedicine, Munster, Germany

* Corresponding author; email: r.arnold{at}dkfz.de.

Life and death of peripheral lymphocytes is strictly controlled to maintain physiological levels of T and B cells. Activation-induced cell death (AICD) is one mechanism to delete superfluous lymphocytes by restimulation of their immunoreceptors and is depends partially on the CD95/CD95L system. Recently, we have shown that hematopoetic progenitor kinase 1 (HPK1) determines T cell fate. While full length HPK1 is essential for NF-{kappa}B activation in T cells, the C-terminal fragment of HPK1, HPK1-C, suppresses NF-{kappa}B and sensitize towards AICD by a yet undefined cell death pathway. Here we show that upon IL-2 driven expansion of primary T cells HPK1 is converted to HPK1-C by a caspase-3 activity below the threshold of apoptosis induction. HPK1-C selectively blocks induction of NF-{kappa}B-dependent anti-apoptotic Bcl-2 family members, but not of the pro-apoptotic Bcl-2 family member Bim. Interestingly, T and B lymphocytes from HPK1-C transgenic mice undergo AICD independently of the CD95/CD95L system, but involving caspase-9. Knock-down of HPK1/HPK1-C or Bim by siRNA shows that CD95L-dependent and HPK1/HPK1-C-dependent cell death pathways complement each other in AICD of primary T cells. Our results define HPK1-C as a suppressor of anti-apoptotic Bcl-2 proteins and provide a molecular basis for our understanding of CD95L-independent AICD of lymphocytes.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Brenner, M. Brechmann, S. Rohling, M. Tapernoux, T. Mock, D. Winter, W. D. Lehmann, F. Kiefer, M. Thome, P. H. Krammer, et al.
Phosphorylation of CARMA1 by HPK1 is critical for NF-{kappa}B activation in T cells
PNAS, August 25, 2009; 106(34): 14508 - 14513.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Alzabin, N. Bhardwaj, F. Kiefer, S. Sawasdikosol, and S. Burakoff
Hematopoietic Progenitor Kinase 1 Is a Negative Regulator of Dendritic Cell Activation
J. Immunol., May 15, 2009; 182(10): 6187 - 6194.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2007 by American Society of Hematology         Online ISSN: 1528-0020